Suppr超能文献

心血管-肝脏-代谢健康:通过改良德尔菲法对心血管疾病中代谢功能障碍相关脂肪性肝病进行筛查、诊断和管理的建议

Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach.

作者信息

Chew Nicholas W S, Mehta Anurag, Goh Rachel Sze Jen, Zhang Audrey, Chen Yiming, Chong Bryan, Chew Han Shi Jocelyn, Shabbir Asim, Brown Adrian, Dimitriadis Georgios K, Huang Daniel Q, Foo Roger, le Roux Carel W, Figtree Gemma A, Fudim Marat, Pandey Ambarish, Mamas Mamas A, Hausenloy Derek J, Richards A Mark, Nicholls Stephen J, Chan Mark Y, Muthiah Mark D, Sanyal Arun, Sperling Laurence S

机构信息

Department of Cardiology, National University Heart Centre (N.W.S.C., A.Z., R.F., M.Y.C.), National University Health System, Singapore.

Yong Loo Lin School of Medicine (N.S.W.C., R.G., Y.C., B.C., D.Q.H., R.F., M.Y.C., M.M., D.J.H.), National University of Singapore, Singapore.

出版信息

Circulation. 2025 Jan 7;151(1):98-119. doi: 10.1161/CIRCULATIONAHA.124.070535. Epub 2024 Dec 26.

Abstract

There is a new awareness of the widespread nature of metabolic dysfunction-associated steatotic liver disease (MASLD) and its connection to cardiovascular disease (CVD). This has catalyzed collaboration between cardiologists, hepatologists, endocrinologists, and the wider multidisciplinary team to address the need for earlier identification of those with MASLD who are at increased risk for CVD. The overlap in the pathophysiologic processes and parallel prevalence of CVD, metabolic syndrome, and MASLD highlight the multisystem consequences of poor cardiovascular-liver-metabolic health. Metabolic dysfunction and associated insulin resistance, together with the predilection for ectopic fat deposition in the liver and surrounding tissues, are associated with elevated risk of endothelial dysfunction, systemic inflammatory response, and ectopic fat deposition in the epicardium. This complex pathophysiology can accelerate atherogenic dyslipidemia, atherogenesis, diastolic dysfunction, valvular calcification, and cardiac arrhythmias. Despite the mounting evidence of mechanistic pathways underpinning MASLD and CVD, current recommendations have not clearly focused upon MASLD as a risk factor or target for intervention in CVD. We have brought together a diverse range of international experts committed to promoting cardiovascular-liver-metabolic health and related outcomes across the globe. The overarching goal of this document is to offer a construct for clinicians in the cardiovascular field with regards to (1) diagnosis and screening of MASLD through the use of noninvasive serum and imaging tests; (2) screening for CVD in all individuals with MASLD regardless of established atherosclerotic risk factors; and (3) the approach to management of MASLD with respect to prevention of CVD through lifestyle, as well as pharmacologic and surgical strategies. To achieve this, the modified Delphi method was applied and a series of evidence-based quality standard recommendations have been identified.

摘要

人们对代谢功能障碍相关脂肪性肝病(MASLD)的广泛存在及其与心血管疾病(CVD)的联系有了新的认识。这促使心脏病专家、肝病专家、内分泌专家以及更广泛的多学科团队展开合作,以满足早期识别那些患CVD风险增加的MASLD患者的需求。CVD、代谢综合征和MASLD在病理生理过程上的重叠以及并行的患病率突出了心血管 - 肝脏 - 代谢健康状况不佳的多系统后果。代谢功能障碍及相关的胰岛素抵抗,连同肝脏和周围组织中异位脂肪沉积的倾向,与内皮功能障碍、全身炎症反应以及心外膜异位脂肪沉积的风险升高相关。这种复杂的病理生理学可加速致动脉粥样硬化性血脂异常、动脉粥样硬化形成、舒张功能障碍、瓣膜钙化和心律失常。尽管有越来越多的证据表明MASLD和CVD的机制途径,但目前的建议尚未明确将MASLD作为CVD的风险因素或干预目标。我们召集了一批致力于在全球范围内促进心血管 - 肝脏 - 代谢健康及相关结果的国际专家。本文档的总体目标是为心血管领域的临床医生提供一个框架,涉及(1)通过使用非侵入性血清和影像学检查诊断和筛查MASLD;(2)对所有MASLD患者进行CVD筛查,无论其是否有已确定的动脉粥样硬化风险因素;以及(3)通过生活方式、药物和手术策略预防CVD来管理MASLD的方法。为实现这一目标,应用了改良的德尔菲法,并确定了一系列基于证据的质量标准建议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验